Westco Advisory Services’s GSK GSK Stock Holding History

Westco Advisory Services’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$214K	Sell	4,090 -335	-8%	-$17.7K	0.13%	97
2026 Q1	$244K	Buy	+4,425	New	+$240K	0.16%	89

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Westco Advisory Services's GSK Position: Q2 2026 in Review

Westco Advisory Services reduced its GSK (GSK) stake by 7.6% in Q2 2026, selling an estimated $17.7K and leaving 4,090 shares worth $214K. The position accounts for 0.13% of the portfolio, ranked #97.

Westco Advisory Services first reported a position in GSK in Q1 2026 and has held it in 2 quarters since. The position peaked at $244K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Westco Advisory Services held 4,090 shares of GSK worth $214K as of Q2 2026.
Westco Advisory Services sold 335 GSK shares in Q2 2026, an estimated $17.7K.
GSK made up 0.13% of Westco Advisory Services's portfolio in Q2 2026, its #97 holding.
Westco Advisory Services first reported a position in GSK in Q1 2026 and has held it in 2 quarters since.
Westco Advisory Services's GSK position peaked at $244K in Q1 2026.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Westco Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.